oleanolic acid has been researched along with Cancer of Prostate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Akbaş, F; Bulut, Ş; Ghaffari-Moghaddam, M; Köse, A; Şenol, H; Topçu, G | 1 |
| Liu, LQ; Tian, FJ; Zhu, WB | 1 |
| Gattass, CR; Martins, CA; Rocha, GDG; Takiya, CM | 1 |
| Arbab, AS; Deeb, D; Gao, X; Gautam, SC; Liu, Y | 1 |
| Lin, X; Liu, G; Liu, J; Liu, M; Ma, L; Wu, N; Zhang, Y | 1 |
| Cao, L; Gao, H; Qu, S; Yang, J; Yao, M; Zhang, L | 1 |
| Chen, L; Li, X; Song, Y; Xiao, Y; Xing, Y; Zhang, P; Zhu, H | 1 |
| Chen, X; Gu, W; Lei, H; Tang, C; Wang, W; Wu, J; Wu, Y; Xiao, W; Xu, H; Zhang, J | 1 |
| Deeb, D; Dulchavsky, SA; Gao, X; Gautam, SC; Jiang, H | 1 |
| Arbab, AS; Deeb, D; Dulchavsky, SA; Gao, X; Gautam, SC; Janic, B; Jiang, H; Rojanasakul, Y | 1 |
| Arbab, AS; Deeb, D; Divine, GW; Dulchavsky, SA; Gao, X; Gautam, SC; Jiang, D; Liu, Y | 1 |
| Ali, MM; Arbab, AS; Deeb, D; Gao, X; Gautam, SC; Iskander, AS; Janic, B; Shankar, A; Varma, NR | 1 |
| Deeb, D; Gao, X; Gautam, SC; Liu, Y | 1 |
| Bomshteyn, A; Hao, M; Katdare, M; Kisilis, E; Oktem, O; Rathnam, P; Saxena, BB; Zhu, L | 1 |
| Fisher, PB; Hyer, ML; Krajewska, M; Lebedeva, IV; Meyer, C; Reed, JC; Shi, R | 1 |
| Deeb, D; Dulchavsky, SA; Gao, X; Gautam, SC | 1 |
| Brodie, AM; Grigoryev, DN; Ling, YZ; Liu, Y; Long, BJ; Nnane, IP | 1 |
| Kim, DS; Kim, JY; Koo, HM | 1 |
18 other study(ies) available for oleanolic acid and Cancer of Prostate
| Article | Year |
|---|---|
Synthesis and Anticancer Activity of Novel Derivatives of α,β-Unsaturated Ketones Based on Oleanolic Acid: in Vitro and in Silico Studies against Prostate Cancer Cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Male; Molecular Docking Simulation; Molecular Structure; Oleanolic Acid; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Structure-Activity Relationship | 2023 |
Chikusetsu (CHI) triggers mitochondria-regulated apoptosis in human prostate cancer via reactive oxygen species (ROS) production.
Topics: Apoptosis; Apoptosis Inducing Factor; Caspases; Cell Line, Tumor; Cell Proliferation; Endodeoxyribonucleases; Humans; Male; Mitochondria; Oleanolic Acid; Prostatic Neoplasms; Reactive Oxygen Species; Saponins; Signal Transduction | 2017 |
Pomolic acid exhibits anticancer potential against a docetaxel‑resistant PC3 prostate cell line.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Humans; Male; Multidrug Resistance-Associated Proteins; Oleanolic Acid; Prostatic Neoplasms | 2019 |
Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer.
Topics: Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation; Humans; Male; Mice; NF-kappa B; Oleanolic Acid; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; STAT3 Transcription Factor; Telomerase | 2012 |
Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms.
Topics: Antineoplastic Agents; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Glycolysis; Heterogeneous Nuclear Ribonucleoprotein A1; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Male; MCF-7 Cells; Membrane Proteins; Mitochondria; Oleanolic Acid; Oxidative Phosphorylation; Prostatic Neoplasms; Protein Isoforms; Proto-Oncogene Proteins c-myc; Pyruvate Kinase; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2014 |
Saikosaponin‑d inhibits proliferation of DU145 human prostate cancer cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cytochromes c; G1 Phase Cell Cycle Checkpoints; Humans; Male; Membrane Potential, Mitochondrial; Oleanolic Acid; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Saponins; Tumor Suppressor Protein p53; Up-Regulation | 2014 |
Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
Topics: Animals; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Cycle; Cell Proliferation; Flow Cytometry; Humans; Immunoenzyme Techniques; In Vitro Techniques; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Oleanolic Acid; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2016 |
Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cysteine Endopeptidases; Epithelial Cells; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Oleanolic Acid; Prostatic Neoplasms; Proteolysis; Sumoylation; Xenograft Model Antitumor Assays | 2016 |
Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
Topics: Animals; Apoptosis; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; NF-kappa B; Nuclear Proteins; Oleanolic Acid; Prostatic Neoplasms; Protein Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Transplantation, Heterologous; Triterpenes | 2009 |
Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.
Topics: Apoptosis; Cell Line, Tumor; Growth Inhibitors; Humans; Male; Oleanolic Acid; Prostatic Neoplasms; Reactive Oxygen Species | 2010 |
Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling.
Topics: Adenocarcinoma; Animals; Animals, Genetically Modified; Apoptosis; Blotting, Western; Cell Proliferation; Disease Progression; Female; Humans; Immunoenzyme Techniques; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Oleanolic Acid; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction | 2011 |
MRI to assess chemoprevention in transgenic adenocarcinoma of mouse prostate (TRAMP).
Topics: Animals; Chemoprevention; Disease Progression; Magnetic Resonance Imaging; Male; Mice; Mice, Transgenic; Oleanolic Acid; Prostate; Prostatic Neoplasms; Seminal Vesicles | 2011 |
Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Male; NF-kappa B; Oleanolic Acid; Prostatic Neoplasms; Protein Phosphatase 2; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; TOR Serine-Threonine Kinases | 2012 |
Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Hydrophobic and Hydrophilic Interactions; Immunohistochemistry; In Vitro Techniques; Lysine; Male; Mice; Mice, Nude; Mitosis; Molecular Conformation; Oleanolic Acid; Prostatic Neoplasms; Solubility; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2006 |
Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Male; Oleanolic Acid; Prostatic Neoplasms; RNA Interference; RNA, Double-Stranded; RNA, Neoplasm; RNA, Small Interfering | 2008 |
CDDO-Me inhibits proliferation, induces apoptosis, down-regulates Akt, mTOR, NF-kappaB and NF-kappaB-regulated antiapoptotic and proangiogenic proteins in TRAMP prostate cancer cells.
Topics: Animals; Animals, Genetically Modified; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Enzyme Inhibitors; Humans; Male; Mice; NF-kappa B; Nitric Oxide; Oleanolic Acid; Prostatic Neoplasms; Protein Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2008 |
Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgen Receptor Antagonists; Androstadienes; Animals; Antineoplastic Agents, Hormonal; Cell Division; Chlorocebus aethiops; Finasteride; Growth Inhibitors; Humans; Ketoconazole; Male; Mice; Mice, Nude; Mice, SCID; Neoplasms, Hormone-Dependent; Oleanolic Acid; Pregnadienes; Prostatic Neoplasms; Receptors, Androgen; Saponins; Steroid 17-alpha-Hydroxylase; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2000 |
Development of C-20 modified betulinic acid derivatives as antitumor agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Betulinic Acid; Drug Screening Assays, Antitumor; Humans; Male; Melanoma; Oleanolic Acid; Pentacyclic Triterpenes; Prostatic Neoplasms; Structure-Activity Relationship; Triterpenes; Tumor Cells, Cultured | 2001 |